178 related articles for article (PubMed ID: 15062358)
1. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck.
Wiseman SM; Stoler DL; Anderson GR
Surg Oncol Clin N Am; 2004 Jan; 13(1):1-11. PubMed ID: 15062358
[TBL] [Abstract][Full Text] [Related]
2. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
3. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?
Deganello A; Franchi A; Sardi I; Pignataro L; Leemans CR; Gallo O
Cancer; 2010 Mar; 116(5):1291-7. PubMed ID: 20087960
[TBL] [Abstract][Full Text] [Related]
5. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
6. Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population.
Chakrabarti S; Sengupta S; Sengupta A; Basak SN; Roy A; Panda C; Roychoudhury S
Mol Carcinog; 2006 Apr; 45(4):270-7. PubMed ID: 16402388
[TBL] [Abstract][Full Text] [Related]
7. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma.
Worsham MJ; Pals G; Schouten JP; Van Spaendonk RM; Concus A; Carey TE; Benninger MS
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):702-8. PubMed ID: 12874067
[TBL] [Abstract][Full Text] [Related]
8. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
9. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
10. Applications of molecular epidemiology to head and neck cancer.
Hart TC
Otolaryngol Clin North Am; 1997 Feb; 30(1):21-34. PubMed ID: 8995134
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
12. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability in squamous cell carcinoma of the head and neck.
Field JK
Anticancer Res; 1996; 16(4C):2421-31. PubMed ID: 8816845
[TBL] [Abstract][Full Text] [Related]
14. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
17. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?
Franchi A; Massi D; Gallo O; Santucci M; Porfirio B
Clin Exp Dermatol; 2006 Nov; 31(6):793-8. PubMed ID: 16824052
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
20. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
